Cargando…
Cost-effectiveness of human papillomavirus vaccination in Germany
BACKGROUND: The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model. METHODS: Based on a mathematical model simulating the transmission dynamics a...
Autores principales: | Damm, Oliver, Horn, Johannes, Mikolajczyk, Rafael T., Kretzschmar, Mirjam E. E., Kaufmann, Andreas M., Deleré, Yvonne, Ultsch, Bernhard, Wichmann, Ole, Krämer, Alexander, Greiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583986/ https://www.ncbi.nlm.nih.gov/pubmed/28878573 http://dx.doi.org/10.1186/s12962-017-0080-9 |
Ejemplares similares
-
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
por: Horn, Johannes, et al.
Publicado: (2018) -
Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
por: Damm, Oliver, et al.
Publicado: (2015) -
Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
por: Scholz, Stefan, et al.
Publicado: (2019) -
Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling
por: Deleré, Yvonne, et al.
Publicado: (2014) -
Cancer incidence in Germany attributable to human papillomavirus in 2013
por: Buttmann-Schweiger, Nina, et al.
Publicado: (2017)